Mercury Laboratories Ltd
BSE:538964
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
|
Mercury Laboratories Ltd
BSE:538964
|
944.9m INR |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
391.4B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
283.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.8B GBP |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Mercury Laboratories Ltd
Glance View
Mercury Laboratories Ltd. engages in the production and sale of pharmaceuticals and its related products. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2015-02-23. The firm is engaged in the manufacturing of pharmaceuticals, medicinal drugs and formulations. The Company’s products include Analgesic, Anti-inflammatory, Anti-pyretic, Anthelmintic, Antibiotic, Anti-coagulant, Anti- platelet, Bleeding agents, Anti-fungal, Anti-hypertensive drugs, Anti-malarial drugs, Cardiovascular System, Central Nervous System, Eye, Gastro-intestinal system, Hypoglycemic (Anti-diabetic), Multivitamin, Protein supplement, Respiratory System, Anti- allergic, Steroids, Urinary system, Uterine stimulant and Miscellaneous. Its products also include Gynec, Paediatric, Surgeon, Physician, Antihypertensive (PIH), PCOS & Uterine Disorders, Galactagogue, Haemostat, Iron and Vitamins, Preterm Labor Management, Antiemetic, Dexamethasone Tablet, Glucosamine Sulphate, Prednisolone Acetate Ophthalmic Suspension USP, Ketorolac Tromethamine 0.4% Eye Drops and Ketorolac Tromethamine 0.4% Eye Drops.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Mercury Laboratories Ltd is 4.9%, which is below its 3-year median of 5.9%.
Over the last 3 years, Mercury Laboratories Ltd’s Net Margin has decreased from 6.5% to 4.9%. During this period, it reached a low of 4.2% on Mar 31, 2025 and a high of 8.9% on Dec 31, 2022.
